MedPath
NMPA Approval

Glimepiride Tablets

国药准字H20205029

May 27, 2022

国药准字H20205029

Drug Information

格列美脲片

佑苏

片剂

1mg

化学药品

May 27, 2022

Company Information

Applicant Company

中国(四川)自由贸易试验区成都市双流区西航港大道中四段2899号

Manufacturing Company

广州高新技术产业开发区广州科学城香山路31号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

格列美脲片 - NMPA 批准文号 | MedPath